Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments


Submitted: April 11, 2018
Accepted: April 11, 2018
Published: June 30, 2018
Abstract Views: 2287
PDF: 1321
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Gianpaolo Perletti Department of Biotechnology and Life Sciences, Section of Medical and Surgical Sciences, Università degli Studi dell'Insubria, Varese, Italy; Faculty of Medicine and Medical Sciences, Ghent University, Ghent, Belgium.
  • Vittorio Magri Urology Secondary Care Clinic, ASST-Nord, Milan, Italy.
  • Tommaso Cai Department of Urology, Santa Chiara Regional Hospital, Trento, Italy.
  • Konstantinos Stamatiou Department of Urology, Tzaneio General Hospital of Piraeus, Piraeus, Greece.
  • Alberto Trinchieri Urology Unit, A. Manzoni Hospital, Lecco, Italy.
  • Emanuele Montanari Department of Urology, University of Milan - Ca' Granda Foundation - Ospedale Maggiore Policlinico, Milan, Italy.
Urinary tract infections are among the most common infectious diseases in humans. Today, resistance to nearly all antimicrobial classes is dramatically growing, and extremely drug-resistant or even pan-drug resistant pathogens are increasingly isolated around the world. It is foreseen that in the next decades the world will be facing a major medical emergency generated by the rapid spread of pathogens carrying resistance determinants of unprecedented power. Carbapenemase-producing Enterobacteriaceae, multidrug- resistant Enterococci and fluoroquinolone resistance determinants in both Gram-negative and Gram-positive uropathogens are among the greatest emergencies. In this article, the major emerging threats of particular interest to urologists are reviewed, worldwide resistance trends are illustrated, and novel and older – but still active – recommended drugs are summarized.

Perletti, G., Magri, V., Cai, T., Stamatiou, K., Trinchieri, A., & Montanari, E. (2018). Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments. Archivio Italiano Di Urologia E Andrologia, 90(2), 85–96. https://doi.org/10.4081/aiua.2018.2.85

Downloads

Download data is not yet available.

Citations